Form 8-K - Current report:
SEC Accession No. 0001193125-26-265852
Filing Date
2026-06-10
Accepted
2026-06-10 16:15:16
Documents
11
Period of Report
2026-06-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sndx-20260610.htm   iXBRL 8-K 78042
2 EX-10.1 sndx-ex10_1.htm EX-10.1 347444
3 EX-10.2 sndx-ex10_2.htm EX-10.2 164231
  Complete submission text file 0001193125-26-265852.txt   769347

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sndx-20260610.xsd EX-101.SCH 24852
14 EXTRACTED XBRL INSTANCE DOCUMENT sndx-20260610_htm.xml XML 4682
Mailing Address 730 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 730 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

EIN.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37708 | Film No.: 261079830
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)